saplin

Compare funds

SBI MultiCap vs Axis Multicap

Both are multi cap funds. Over the last 3 years SBI MultiCap returned 13.7% a year and Axis Multicap 19.9%, against a category median of 15.1%. SBI MultiCap costs 1.04% a year and Axis Multicap 0.90%. On the saplin Score SBI MultiCap rates 5.7 (Weak) and Axis Multicap 9.1 (Strong) within their category. 24.4% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

SBI MultiCapAxis MulticapCategory median
saplin Score (0–10)5.7 Weak9.1 Strong—
1-year return1.7%12.0%6.2%
3-year return, a year13.7%19.9%15.1%
5-year return, a year——13.4%
Volatility (standard deviation)14.7%16.3%16.8%
Sharpe ratio0.500.830.56
Beta0.830.920.94
Upside capture87113104
Downside capture778895
Expense ratio (Direct)1.04%0.90%0.95%
Fund size₹24,132 cr₹11,430 cr₹3,488 cr
Number of holdings7110578
Top 10 holdings, share of fund28.9%24.2%27.0%
Portfolio P/E33.934.328.7
Lead managerRuchit Mehta (1 yr)Nitin Arora (4 yrs)—
Launched8 Mar 202217 Dec 2021—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

SBI MultiCap and Axis Multicap have 24.4% of their portfolios in the same stocks (25 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsSBI MultiCapAxis Multicap
ICICI Bank4.28%3.37%
HDFC Bank3.03%2.60%
Divi's Laboratories3.64%2.58%
Sona BLW Precision Forgings1.95%2.66%
BSE1.23%1.26%
The Federal Bank1.49%1.16%
Coforge1.90%1.13%
Eternal1.08%3.05%
Navin Fluorine International1.14%1.04%
FSN E-Commerce Ventures1.22%1.03%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.